Stocks
Latest stock market news — earnings, indices, equities, and corporate events explained for retail investors.
1151 articles in Stocks — page 5 of 96
StocksUBS Optimistic About Swiss Stocks Due to Valuations and Dividends
UBS maintains a positive outlook on Swiss equities, highlighting their attractive valuations and strong dividends.
StocksGrifols Plans U.S. Biopharma IPO to Reduce Debt and Boost Growth
Grifols announces IPO for its U.S. biopharma unit to raise funds for debt reduction and growth.
StocksUK Oil & Gas Partners with Wales & West Utilities for Hydrogen Storage Initiative
UK Oil & Gas's subsidiary teams up with Wales & West Utilities to enhance hydrogen storage in South Dorset.
StocksUBS Highlights Swiss Equities Amid Global Uncertainty
UBS sees Swiss stocks as appealing due to their quality and defensive nature during geopolitical tensions.
StocksChina's Food-Delivery Stocks Surge as Regulators Address Price Wars
Shares of major Chinese food-delivery companies rise as regulators aim to reduce fierce competition.
StocksFastweb and Vodafone Move to End Tower Agreement with Inwit
Fastweb and Vodafone seek to terminate their agreement with Inwit due to high costs and lack of negotiations.
StocksUK Stocks and Pound Rise Amid U.S.-Iran Talks; Inflation Steady
UK stocks and the pound gained as hopes for U.S.-Iran talks emerged, while inflation remained steady.
StocksMorgan Stanley Upgrades Prosus to Overweight, Sees 29% Potential Growth
Morgan Stanley has upgraded Prosus, predicting a 29% increase based on its current stock discount.
StocksQuartix Reports 12% Revenue Growth for 2025
Quartix, a UK vehicle tracking company, sees significant revenue and profit growth in 2025.
StocksFranchise Brands Reports 2% Sales Growth for 2025
Franchise Brands sees a 2% rise in system sales for 2025, reaching £434.99 million amid challenging conditions.
StocksPharos Energy Reports Revenue Decline Due to Lower Oil Prices
Pharos Energy's revenue drops in 2025 as oil prices fall, leading to a net loss for the year.
StocksAptamer Group Sees 27% Revenue Growth Thanks to Pharma Contracts
Aptamer Group reports a significant revenue increase, driven by contracts with pharmaceutical companies.